Skip to main content

Table 1 Baseline demographic and laboratory parameters of the patients (BMI: body mass index, LVH: left ventricular hypertrophy, LVMI: left ventricular mass index, CIMT: carotid intima-media thickness, FMD: flow mediated diltation, CRP: C-reactive protein, TNF-α: tumor necrosis factor-α, IL-6: interleukin-6)

From: CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients

Parameters

All patients (n = 58)

High CD133+ group

Low CD133+ group

p value a

Age(years)

58 ± 15

56 ± 17

60 ± 12

0.30

Gender (M/F)

28/30

15/14

13/16

0.50

Dialysis intage (months)

81.6 ± 44.4

7.35 ± 3.92

6.50–3.55

0.40

Kt/V

1.88 ± 0.34

1.89 ± 0.31

1.87 ± 0.38

0.79

BMI (kg/m2)

25 ± 5

26 ± 4

24 ± 5

0.14

LVH (n,%)

19 (33%)

11 (38%)

8 (27%)

0.36

LVMI (g/m2)

114 ± 29

118 ± 28

109 ± 30

0.31

Carotid plaque (n,%)

25 (43%)

11 (37%)

14 (48%)

0.37

CIMT (mm)

0.87 ± 0.19

0.86 ± 0.17

0.88 ± 0.22

0.80

FMD (%)

6.41 (2.80–10.80)

3.46 (0.88–9.63)

8.50 (6.12–12.51)

0.02

Hemoglobin (g/dL)

11.88 ± 1.24

12.16 ± 1.40

11.61 ± 1.03

0.10

Albumin (g/dL)

4.09 ± 0.24

4.15 ± 0.24

4.03 ± 0.22

0.04

CRP (mg/dL)

0.74 (0.38–1.41)

0.70(0.38–1.20)

0.80(0.46–1.53)

0.73

TNF-α (pg/mL)

31.64(23.81–61.29)

54.51(28.92–70.08)

26.19(22.15–37.29)

0.002

IL-6 (pg/mL)

11.71 (8.22–21.12)

12.29(8.69–22.94)

11.31(5.82–17.81)

0.46

Leptin (ng/mL)

23.58(7.12–54.22)

32.37(12.74–72.29)

15.50(5.38–37.12)

0.03

Adiponectin(μg/mL)

30.42(20.45–45.11)

26(18.38–37.85)

31.81(22.82–45.25)

0.25

Resistin (ng/mL)

3.25(2.30–4.30)

3.92(3–5.13)

2.91(1.89–3.34)

<0.001

CD133+ cell count (%)

0.80(0.60–1.00)

1(0.85–1.27)

0.6(0.51–0.65)

<0.001

  1. aComparison of the results between high and low CD133+ groups